ANAVAR 10

DESCRIPTION
Oxandrolone 10 is a well tolerated 17-alpha alkylated anabolic steroid with very low hepatic
toxicity. It promotes anabolism through androgen receptor activity and has a low incidence of
adverse reactions. When taken in clinical doses, oxandrolone promotes improvements in
strength and moderate increases in muscle mass. Oxandrolone has been demonstrated to
enhance body fat reduction significantly in both the abdominal and visceral stores (Int. J.
Obesity, 1995; 19: 614-624). Oxandrolone will not aromatize and therefore the anabolic
effect of this compound can promote linear growth. Oxandrolone has shown great promise in
nerve regeneration, skin healing in burn victims, and increased rate of healing after traumatic
events.

INDICATIONS
Oxandrolone 10 is indicated as an alternate or adjunctive therapy in patients for the
promotion of weight gain following weight loss and/or muscular atrophy associated with
extensive surgery, chronic infections, long term hospitalization, or severe trauma. Oxandro
10 is indicated to compensate for protein catabolism consequent to corticosteroid therapy
and for the reduction of pain associated with osteoporosis.

ADVERSE REACTIONS
Male: Gynecomastia, excessive frequency and duration of penile erections, oligospermia.
Skin and Appendages: Hirsutism, male pattern baldness and acne, gynecomastia.
Fluid/electrolyte Disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular neoplasms, peliosis hepatis, hepatic adenomas, and
cholestatic hepatitis.
Hematologic: Suppression of clotting factors II, V, VII, & X: bleeding in patients on anti- coagulant therapy.
Nervous System: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Other: Serum lipid changes, hypercalcaemia, hypertension, oedema, priapism, and potentiation of sleep apnea.

CONTRAINDICATIONS
Patients with diagnosed or suspected carcinoma of the breast, prostate, or testis. Women
who are pregnant or may become pregnant because of possible masculinization of the fetus.
Patients with nephrosis or the nephrotic phase of nephritis. Patients with hypercalcemia.
Patients with pre-existing cardiac, respiratory, renal, and/or hepatic disease or history of
epilepsy.

DOSAGE AND ADMINISTRATION
Adult males: 10 – 30 mg taken orally per day in 2 to 3 divided doses for 6 to 8 weeks under
care of a physician.

PRESENTATION
Oxandrolone 10 mg uncoated tablets: 100 tablets in blister

STORAGE
Store in a cool dry place between 15 – 25°C, Protect from beau light.